HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A preliminary report on ABO incompatible bone marrow transplant.

AbstractBetween September 1985 and June 1990, five patients with major and six patients with minor ABO blood group incompatibility between donor and recipient underwent allogeneic bone marrow transplantation (BMT) in the Singapore General Hospital. The period to engraftment, rate of recovery of peripheral blood leukocytes, granulocytes, and platelets and the incidence of graft versus host disease (GVHD) was similar to that observed following ABO blood group compatible marrow transplant. Erythroid development and reticulocytosis were, however, significantly delayed in patients receiving major ABO incompatible marrow transplant.
AuthorsP Tan, Y W Ong, S L Tien, T F Loh, S T Lim (Affiliation: Department of Haematology, Singapore General Hospital.)
JournalAnnals of the Academy of Medicine, Singapore (Ann Acad Med Singapore) Vol. 20 Issue 4 Pg. 421-8 (Jul 1991) ISSN: 0304-4602 [Print] SINGAPORE
PMID1799251 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • ABO Blood-Group System
  • HLA Antigens
Topics
  • ABO Blood-Group System (immunology)
  • Adolescent
  • Adult
  • Bone Marrow Transplantation (immunology, methods)
  • Dose-Response Relationship, Immunologic
  • Female
  • Graft Survival (immunology)
  • Graft vs Host Disease (prevention & control)
  • HLA Antigens (immunology)
  • Histocompatibility (immunology)
  • Humans
  • Immunosuppression (methods)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD